These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1446 related items for PubMed ID: 16552474

  • 1. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
    Moolman JA, Hartley S, Van Wyk J, Marais E, Lochner A.
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
    [Abstract] [Full Text] [Related]

  • 2. p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning.
    Marais E, Genade S, Strijdom H, Moolman JA, Lochner A.
    J Mol Cell Cardiol; 2001 Dec; 33(12):2157-77. PubMed ID: 11735262
    [Abstract] [Full Text] [Related]

  • 3. The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical.
    Mocanu MM, Baxter GF, Yue Y, Critz SD, Yellon DM.
    Basic Res Cardiol; 2000 Dec; 95(6):472-8. PubMed ID: 11192368
    [Abstract] [Full Text] [Related]

  • 4. Kinases and phosphatases in ischaemic preconditioning: a re-evaluation.
    Fan WJ, van Vuuren D, Genade S, Lochner A.
    Basic Res Cardiol; 2010 Jul; 105(4):495-511. PubMed ID: 20127248
    [Abstract] [Full Text] [Related]

  • 5. The significance of the washout period in preconditioning.
    Salie R, Lochner A, Loubser DJ.
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28118517
    [Abstract] [Full Text] [Related]

  • 6. Activation of p38 MAPK induced by a multi-cycle ischaemic preconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion.
    Marais E, Genade S, Huisamen B, Strijdom JG, Moolman JA, Lochner A.
    J Mol Cell Cardiol; 2001 Apr; 33(4):769-78. PubMed ID: 11273729
    [Abstract] [Full Text] [Related]

  • 7. CREB activation and ischaemic preconditioning.
    Marais E, Genade S, Lochner A.
    Cardiovasc Drugs Ther; 2008 Feb; 22(1):3-17. PubMed ID: 18205034
    [Abstract] [Full Text] [Related]

  • 8. Protection of the ischaemic heart: investigations into the phenomenon of ischaemic preconditioning.
    Lochner A, Marais E, Genade S, Huisamen B, du Toit EF, Moolman JA.
    Cardiovasc J Afr; 2009 Feb; 20(1):43-51. PubMed ID: 19287816
    [Abstract] [Full Text] [Related]

  • 9. Comparison between ischaemic and anisomycin-induced preconditioning: role of p38 MAPK.
    Lochner A, Genade S, Hattingh S, Marais E, Huisamen B, Moolman JA.
    Cardiovasc Drugs Ther; 2003 May; 17(3):217-30. PubMed ID: 14574080
    [Abstract] [Full Text] [Related]

  • 10. Role of p38-mitogen-activated protein kinase in ischaemic preconditioning in rat heart.
    Bell JR, Eaton P, Shattock MJ.
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):126-34. PubMed ID: 17892505
    [Abstract] [Full Text] [Related]

  • 11. The temporal relationship between p38 MAPK and HSP27 activation in ischaemic and pharmacological preconditioning.
    Marais E, Genade S, Salie R, Huisamen B, Maritz S, Moolman JA, Lochner A.
    Basic Res Cardiol; 2005 Jan; 100(1):35-47. PubMed ID: 15526116
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
    Bliksøen M, Kaljusto ML, Vaage J, Stensløkken KO.
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
    [Abstract] [Full Text] [Related]

  • 14. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
    Chai W, Wu Y, Li G, Cao W, Yang Z, Liu Z.
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury.
    Zhao TC, Cheng G, Zhang LX, Tseng YT, Padbury JF.
    Cardiovasc Res; 2007 Dec 01; 76(3):473-81. PubMed ID: 17884027
    [Abstract] [Full Text] [Related]

  • 16. Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK.
    Nakano A, Baines CP, Kim SO, Pelech SL, Downey JM, Cohen MV, Critz SD.
    Circ Res; 2000 Feb 04; 86(2):144-51. PubMed ID: 10666409
    [Abstract] [Full Text] [Related]

  • 17. The mechanism of beta-adrenergic preconditioning: roles for adenosine and ROS during triggering and mediation.
    Salie R, Moolman JA, Lochner A.
    Basic Res Cardiol; 2012 Sep 04; 107(5):281. PubMed ID: 22797560
    [Abstract] [Full Text] [Related]

  • 18. The relative order of mK(ATP) channels, free radicals and p38 MAPK in preconditioning's protective pathway in rat heart.
    Yue Y, Qin Q, Cohen MV, Downey JM, Critz SD.
    Cardiovasc Res; 2002 Aug 15; 55(3):681-9. PubMed ID: 12160965
    [Abstract] [Full Text] [Related]

  • 19. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart.
    Weinbrenner C, Liu GS, Cohen MV, Downey JM.
    J Mol Cell Cardiol; 1997 Sep 15; 29(9):2383-91. PubMed ID: 9299362
    [Abstract] [Full Text] [Related]

  • 20. Myocardial susceptibility to ischaemia/reperfusion in obesity: a re-evaluation of the effects of age.
    Webster I, Salie R, Marais E, Fan WJ, Maarman G, Huisamen B, Lochner A.
    BMC Physiol; 2017 Mar 17; 17(1):3. PubMed ID: 28302152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 73.